5 Oversold Biotech Stocks To Buy Right Now

Page 5 of 5

1. AN2 Therapeutics Inc. (NASDAQ:ANTX)

Number of Hedge Fund Holders: 17

14-day RSI Value: 17.4

A Market Perform rating and $7 price target were maintained on AN2 Therapeutics Inc. (NASDAQ:ANTX) on February 13 by Joseph Schwartz at Leerink Partners.

There were 17 hedge funds long AN2 Therapeutics Inc. (NASDAQ:ANTX) in the fourth quarter, with a total stake value of $252.1 million.

AN2 Therapeutics Inc. (NASDAQ:ANTX) is a clinical-stage biotech company that develops treatments for rare, chronic, and serious infectious diseases. It is based in Menlo Park, California.

Follow An2 Therapeutics Inc.

See also 12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds and 10 Biotech Stocks with Huge Potential.

Page 5 of 5